Alvaro Guzman
Psychiatry · Washington, DCNPI 1568524668
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.3% of the total across 110 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 21 manufacturers, the largest accounting for just 18.7% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $1,105 and has fallen 90.0% since, to $110 in 2025.
Across 110 payments — averaging $18.67 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Lundbeck LLC$384
- Johnson & Johnson$223
- Sunovion Pharmaceuticals Inc.$208
- Viiv Healthcare Company$190
- Teva Pharmaceuticals USA, Inc.$152
- Takeda Pharmaceuticals U.S.A., Inc.$122
- plus $775 from 15 others
What the payments were for
- Food & beverage$2,03999%
- Education$151%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Lundbeck LLC | 20 | $384 |
| Johnson & Johnson(2 entities) | 9 | $223 |
| Sunovion Pharmaceuticals Inc. | 14 | $208 |
| Viiv Healthcare Company | 8 | $190 |
| Teva Pharmaceuticals USA, Inc. | 12 | $152 |
| Takeda Pharmaceuticals U.S.A., Inc. | 6 | $122 |
| AbbVie(2 entities) | 8 | $115 |
| Bausch Health US, LLC | 5 | $114 |
| Indivior Inc. | 4 | $94 |
| Gilead | 4 | $92 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 4 | $81 |
| Otsuka America Pharmaceutical, Inc. | 3 | $62 |
| Vanda Pharmaceuticals Inc. | 3 | $61 |
| Neos Therapeutics, LP | 2 | $32 |
| Merck | 2 | $27 |
| Ironshore Pharmaceuticals Inc. | 1 | $21 |
| Napo Pharmaceuticals Inc | 1 | $18 |
| Shire North American Group Inc | 1 | $16 |
| Axsome Therapeutics, Inc. | 1 | $16 |
| Avion Pharmaceuticals | 1 | $14 |
| Eisai Inc. | 1 | $12 |
How this compares
$2,054 in reported general payments places this provider in the 85th percentile of 226 psychiatry providers in District of Columbia.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| RexultiBrexpiprazole | 22 | $58,777 |
| TrintellixVortioxetine Hydrobromide | 11 | $12,302 |
| Dextroamphetamine Sulfate | 21 | $4,316 |
| Alprazolam | 132 | $1,881 |
| Bupropion XlBupropion Hcl | 45 | $1,850 |
| Fluoxetine Hcl | 34 | $1,314 |
| Lurasidone Hcl | 13 | $1,266 |
| Escitalopram Oxalate | 27 | $867 |
| Aripiprazole | 17 | $840 |
| Sertraline Hcl | 49 | $832 |
| Clonazepam | 73 | $803 |
| Mirtazapine | 38 | $803 |
| Trazodone Hcl | 65 | $686 |
| Venlafaxine Hcl ErVenlafaxine Hcl | 19 | $605 |
| Carisoprodol | 27 | $604 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Otsuka America Pharmaceutical, Inc.Rexulti | $62 | $58,77722 claims |
| Takeda Pharmaceuticals U.S.A., Inc.Trintellix | $122 | $12,30211 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 226 psychiatry providers in District of Columbia.
Other psychiatry in Washington
- Ikechi NnawuchiWashington$624K
- James GordonWashington$20K
- Thomas MellmanWashington$19K
- Tony GoreWashington$11K
- Dwight KingWashington$10K
- Igor VolkovWashington$10K
- Joel KleinmanWashington$8K
- Vivienne GomesWashington$6K
- Irfan SaeedWashington$6K
- Arda KasaciWashington$5K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.